Melanoma Clinical Trials

Showing 1441-1460 of 1,477 trials

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

NCT00735332

The objective of this study is to assess the efficacy and safety of TLN-232 used to treat patients with metastatic melanoma that recur/progress after receiving first line systemic therapy.

Melanoma

Thallion Pharmaceuticals49 participantsStarted Aug 2008

Philadelphia, Pennsylvania, United States • Hamilton, Ontario, Canada • Toronto, Ontario, Canada +1 more locations

COMPLETEDPhase 1

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

The present clinical trial is a dose comparison of a multi-component active immunotherapy designed to stimulate an immune reaction to specific tumor associated antigens which are highly expressed on a large number of solid cancers.

OvarianMelanomaRenal+20 more

Mannkind Corporation12 participantsStarted Feb 2007

Tuscon, Arizona, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +2 more locations

SUSPENDED

Confocal Microscopy of Benign and Malignant Skin Tumors

NCT01010321

The investigators speculate that this tool may be used as an alternative and convenient non-invasive diagnostic of skin cancer.

Skin Cancer

Sheba Medical Center60 participantsStarted Nov 2009

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Confocal Microscopy of Benign and Malignant Skin Tumors

Related Searches

Quality of Life and Psychological Well-being in Patients With Malignant Melanoma

Biological Therapy in Treating Patients With Metastatic Melanoma

Long-term Data Collection for Subjects in MDX-010 Studies

The Impact of Total Body Skin Examination on Skin Cancer Detection

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

CPG 7909 Injection in Melanoma

Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer

Temodar and Sutent as Therapy for Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Sentinel Node With Ultrasound Contrast in Melanoma